Evidence map›Paper›PMID 37341633›Full record

ArticleInterdisciplinary cardiovascular and thoracic surgery2023

Pulmonary valve reconstruction for acquired pulmonary regurgitation in patients with treated congenital heart disease.

Jill Jussli-Melchers, Jan Hinnerk Hansen, Jens Scheewe, Tim Attmann, Martin Eide, Jana Logoteta, Peter Dütschke, Mona Salehi Ravesh, Anselm Uebing, Inga Voges

Open access · diamondAbstract read
In one paragraph

Article in Interdisciplinary cardiovascular and thoracic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jill Jussli-MelchersDepartment of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0002-6534-087X
Jan Hinnerk HansenDepartment of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0003-1575-2865
Jens ScheeweDepartment of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0002-8038-9313
Tim AttmannDepartment of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0002-5991-2106
Martin EideDepartment of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Kiel, Germany.
Jana LogotetaDepartment of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0002-1914-4675
Peter DütschkeDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Kiel, Germany.
Mona Salehi RaveshDepartment of Radiology and Neuroradiology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0003-2636-7508
Anselm UebingDepartment of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0001-8504-0228
Inga VogesDepartment of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0001-7406-8006
University Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPulmonary valve regurgitation is a common problem after relief of right ventricular outflow tract (RVOT) obstruction with a transannular patch. Pulmonary valve replacement with a homograft or xenograft is the routine treatment. Longevity of biological valves and the availability of homografts are limited. Alternatives to restore RVOT competence are evaluated. The goal of this study was to present intermediate-term results for pulmonary valve reconstruction (PVr) in patients with severe regurgitation.

methodsPVr was performed in 24 patients (August 2006‒July 2018). We analysed perioperative data, pre- and postoperative cardiac magnetic resonance (CMR) imaging studies, freedom from valve replacement and risk factors for pulmonary valve dysfunction.

resultsThe underlying diagnoses were tetralogy of Fallot (n = 18, 75%), pulmonary stenosis (n = 5, 20.8%) and the double outlet right ventricle post banding procedure (n = 1, 4.2%). The median age was 21.5 (14.8-23.7) years. Main (n = 9, 37.5%) and branch pulmonary artery procedures (n = 6, 25%) and surgery of the RVOT (n = 16, 30.2%) were often part of the reconstruction. The median follow-up after the operation was 8.0 (4.7-9.7) years. Freedom from valve failure was 96% at 2 and 90% at 5 years. The mean longevity of the reconstructive surgery was 9.9 years (95% confidence interval: 8.8-11.1 years). CMR before and 6 months after surgery showed a reduction in the regurgitation fraction [41% (33-55) vs 20% (18-27) P = 0.00] and of the indexed right ventricular end-diastolic volume [156 ml/m2 (149-175) vs 116 ml/m2 (100-143), P = 0.004]. Peak velocity across the pulmonary valve (determined by CMR) half a year after surgery was 2.0, unchanged.

conclusionsPVr can be achieved with acceptable intermediate-term results and may delay pulmonary valve replacement.

Indexed as

CMR evaluationCongenital heart surgeryPulmonary valve reconstruction

Identifiers

PMID37341633
PMCPMC10581336
OpenAlexW4381469988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.